Barbara Ann Karmanos Cancer Institute - Lawrence and Idell Weisberg Cancer Treatment Center is a clinical research site located in Detroit, Michigan, United States 48201.
Crixeo Health Trust Score: 55/100 (POOR). This profile has not yet been claimed by the site owner.
Barbara Ann Karmanos Cancer Institute - Lawrence and Idell Weisberg Cancer Treatment Center has participated in 2 clinical trials with 1 currently active.
Therapeutic areas: Solid Neoplasms, Advanced Cholangiocarcinoma, FGFR2 Gene Mutation.
Sponsors: Takeda, QED Therapeutics, a BridgeBio company.
Trust Score: 55/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Barbara Ann Karmanos Cancer Institute - Lawrence and Idell Weisberg Cancer Treatment Center has a Crixeo Trust Score of 55/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Barbara Ann Karmanos Cancer Institute - Lawrence and Idell Weisberg Cancer Treatment Center has 2 clinical trials on record, with 1 currently active. Their work covers Solid Neoplasms, Advanced Cholangiocarcinoma, FGFR2 Gene Mutation.
Barbara Ann Karmanos Cancer Institute - Lawrence and Idell Weisberg Cancer Treatment Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.